Two Toronto startups are developing psilocybin-based medications that could expand treatment options for those in need.

Psychedelic drugs had become more readily available to the public, and Witt—a contributor to publications including The New ...

More than 5 million Americans in treatment for depression could benefit from therapy with psilocybin -- the active ingredient ...

The U.S. Food and Drug Administration (FDA) has issued a complete response letter for MDMA-assisted psychotherapy (MDMA-AT) ...

The University of Virginia Health Toxicology Laboratory found psilocin (a psychoactive compound in magic mushrooms) in one product — but in hundreds of clinical studies, psilocin hasn’t caused these ...

Moxy, a powerful psychedelic, is gaining global momentum. With new FDA approved trials investigating its potential to treat ...

Psychedelics are often associated with the counterculture of the 1960s, embraced by hippies as a way to "turn on, tune in, ...

Mike Tyson's recent comments about using psychedelic mushrooms during training brought to the surface a practice taking place ...

She has even published a book about microdosing, inspired by the changes psilocybin has brought to her life. Her before-and-after story about how mushrooms changed her management style adds ...

This journal utilises an Online Peer Review Service (OPRS) for submissions. By clicking "Continue" you will be taken to our partner site https://www.editorialmanager ...